Therapeutic Asset Ratings

234 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Dostarlimab Germline BRCA2 Gene Mutation	Dana-Farber Cancer Institute	P2	CCC (53)
Epirubicin PD-L1 Negative	Dana-Farber Cancer Institute	P2	CCC (53)
Eribulin Chemotherapy-induced Alopecia	Dana-Farber Cancer Institute	P2	CCC (53)
EXEMESTANE Ataxia Telangiectasia Mutated Gene Mutation	Dana-Farber Cancer Institute	P2	CCC (53)
EXEMESTANE Atypical Lobular Hyperplasia	Dana-Farber Cancer Institute	P2	CCC (53)
EXEMESTANE BRCA2 Mutation	Dana-Farber Cancer Institute	P2	CCC (53)
EXEMESTANE CHEK2 Gene Mutation	Dana-Farber Cancer Institute	P2	CCC (53)
EXEMESTANE Ductal Carcinoma	Dana-Farber Cancer Institute	P2	CCC (53)
Fludarabine Smoldering Multiple Myeloma	Dana-Farber Cancer Institute	P2	CCC (53)
Ipilimumab Adrenal Cortical Carcinoma	Dana-Farber Cancer Institute	P2	CCC (53)
Ipilimumab Non-urothelial Bladder	Dana-Farber Cancer Institute	P2	CCC (53)
Ipilimumab Refractory Germ-cell	Dana-Farber Cancer Institute	P2	CCC (53)
Marizomib Multiple Myeloma	Dana-Farber Cancer Institute	P2	CCC (53)
Metformin Monoclonal Gammopathy of Undetermined Significance	Dana-Farber Cancer Institute	P2	CCC (53)
Metformin Smoldering Multiple Myeloma	Dana-Farber Cancer Institute	P2	CCC (53)
Nivolumab Refractory Germ-cell	Dana-Farber Cancer Institute	P2	CCC (53)
Olaparib Mucosal Melanoma	Dana-Farber Cancer Institute	P2	CCC (53)
Ruxolitinib Inflammatory Breast Cancer (IBC)	Dana-Farber Cancer Institute	P2	CCC (53)
TAMOXIFEN Ataxia Telangiectasia Mutated Gene Mutation	Dana-Farber Cancer Institute	P2	CCC (53)
TAMOXIFEN BRCA2 Mutation	Dana-Farber Cancer Institute	P2	CCC (53)
TAMOXIFEN Breast Atypical Lobular Hyperplasia	Dana-Farber Cancer Institute	P2	CCC (53)
TAMOXIFEN CHEK2 Gene Mutation	Dana-Farber Cancer Institute	P2	CCC (53)
TAMOXIFEN Ductal Carcinoma	Dana-Farber Cancer Institute	P2	CCC (53)
Trastuzumab Deruxtecan Chemotherapy-induced Alopecia	Dana-Farber Cancer Institute	P2	CCC (53)
Trastuzumab Emtansine ER Positive Breast Cancer	Dana-Farber Cancer Institute	P2	CCC (53)

Showing 76 to 100 of 234 assets

PreviousPage 4 of 10Next